BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12800369)

  • 1. APD schedules and clinical results.
    Durand PY
    Contrib Nephrol; 2003; (140):272-7. PubMed ID: 12800369
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?
    Diaz-Buxo JA
    Contrib Nephrol; 2003; (140):264-71. PubMed ID: 12800368
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten years after MIDAS: icodextrin lights and shadows.
    Amici G; Da Rin G; Agostini A; Velo S; Bocci C
    Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
    Feriani M
    Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
    [No Abstract]   [Full Text] [Related]  

  • 5. Peritonitis - does peritoneal dialysis modality make a difference?
    Piraino B; Sheth H
    Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for sorbents in continuous flow peritoneal dialysis.
    Winchester JF; Brady JA; Salsberg JA; Mok W; Quartararo PJ
    Contrib Nephrol; 2003; (140):305-8. PubMed ID: 12800372
    [No Abstract]   [Full Text] [Related]  

  • 7. PD: a biological membrane and a non-biological fluid.
    Jörres A
    Contrib Nephrol; 2003; (140):1-9. PubMed ID: 12800338
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal microcirculation.
    Lameire N; Mortier S; De Vriese A
    Contrib Nephrol; 2003; (140):56-69. PubMed ID: 12800344
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
    MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
    Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
    Sanchez AR; Madonia C; Rascon-Pacheco RA
    Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal Dialysis Adequacy in Elderly Patients.
    Oei E; Fan S
    Perit Dial Int; 2015 Nov; 35(6):635-9. PubMed ID: 26702004
    [No Abstract]   [Full Text] [Related]  

  • 13. GDPs and AGEs: local and systemic effects in PD patients.
    Ledebo I; Wieslander A; Deppisch R
    Contrib Nephrol; 2003; (140):38-46. PubMed ID: 12800342
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results with low glucose degradation product content in peritoneal dialysis fluids.
    Rippe B; Wieslander A; Musi B
    Contrib Nephrol; 2003; (140):47-55. PubMed ID: 12800343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standard methods of peritoneal dialysis (PD) and standard peritoneal dialysis solutions in the future in Japan].
    Nakamoto H
    Nihon Jinzo Gakkai Shi; 2009; 51(7):864-74. PubMed ID: 19928560
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
    Krediet RT
    Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous flow peritoneal dialysis: current perspectives.
    Amerling R; Glezerman I; Savransky E; Dubrow A; Ronco C
    Contrib Nephrol; 2003; (140):294-304. PubMed ID: 12800371
    [No Abstract]   [Full Text] [Related]  

  • 19. Ecology of the peritoneum: a substantial role for the osmotic agents resulting in apoptosis of mesothelial cells.
    Gotloib L; Wajsbrot V; Shostak A
    Contrib Nephrol; 2003; (140):10-7. PubMed ID: 12800339
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance of functioning PD access and management of complications.
    Verger C
    Contrib Nephrol; 2004; 142():410-21. PubMed ID: 14719407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.